Actively Recruiting
Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation
Led by Massachusetts General Hospital · Updated on 2026-04-24
40
Participants Needed
1
Research Sites
64 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
A
American Society of Transplantation and Cellular Therapy
Collaborating Sponsor
AI-Summary
What this Trial Is About
Primary PC - or training HCT clinicians to deliver PC domains as part of routine practice - is an alternative model of supportive care. We have developed Sentinel, a primary PC intervention for HCT clinicians and patients. This study will assess Sentinel's feasibility and acceptability.
CONDITIONS
Official Title
Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Undergoing autologous or allogeneic hematopoietic cell transplantation at MGH
You will not qualify if you...
- Prior receipt of inpatient specialty palliative care on two prior admissions in the past 6 months
- Significant uncontrolled psychiatric disorders such as psychotic disorder, bipolar disorder, or major depression
- Other co-morbid diseases like dementia or cognitive impairment that prevent informed consent or participation
- Inability to comprehend English as this is a preliminary/pilot study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02152
Actively Recruiting
Research Team
R
Richard A Newcomb, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here